Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on INSP stock, giving a Buy rating yesterday. Anthony ...

Gov. Josh Shapiro and First Lady Lori Shapiro hosted Pennsylvania veterans for a luncheon this week at the Governor’s ...

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

The people gathered for Are Media's Ignite event in Sydney yesterday. No news on the return of Rugby League Week.

This adjustment follows Inspire Medical (TASE:PMCN)'s recent financial performance, which included a revenue and earnings per share (EPS) beat, alongside raised forecasts. The company has reported ...

Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

Inspire expects full-year earnings to be $1.20 to $1.40 per share, with revenue in the range of $793 million to $798 million. This story was generated by Automated Insights ( ...

Minda Harts, the author of the advice book "The Memo," spoke to Business Insider about adapting her book to the screen.

One of the most powerful motivators for any individual is a connection to a greater purpose or ultimate intent.

Whether you're introducing yourself at a networking event, telling new colleagues about your business, or pitching to an ...